Quick Answer
EXAGEN INC. reported Cash and Equivalents of $32.22 million for fiscal year 2025.
EXAGEN INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $32.22M | +46.2% |
| 2024 | $22.04M | -39.6% |
| 2023 | $36.49M | -41.5% |
| 2022 | $62.39M | -37.3% |
| 2021 | $99.44M | +73.1% |
| 2020 | $57.45M | -20.3% |
| 2019 | $72.08M | +447.6% |
| 2018 | $13.16M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $35.65M | +61.8% | +18.7% |
| June 30, 2025 | $30.03M | +22.7% | +168.3% |
| March 31, 2025 | $11.19M | -58.9% | -49.2% |
| December 31, 2024 | $22.04M | -39.6% | +0.0% |
| September 30, 2024 | $22.04M | -22.5% | -10.0% |
| June 30, 2024 | $24.48M | -22.2% | -10.2% |
| March 31, 2024 | $27.27M | -47.7% | -25.3% |
| December 31, 2023 | $36.49M | -41.5% | +28.3% |
- EXAGEN INC. showed an increase of +46.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2018–2025 period, EXAGEN INC.’s cash and equivalents has grown by 144.8% (from $13.16 million to $32.22 million).
- The most recent figure is from EXAGEN INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: